Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel

Suszeptibilität für Lupus-Nephritis

Die Schwere einer Nierenbeteiligung bei systemischem Lupus erythematodes kann durch genetische Varianten im FCGR2A-Gen, welches einen Immunglobulinrezeptor kodiert, beeinflusst werden.

Gliederung

Suszeptibilität für systemischen Lupus erythematodes
Anfälligkeit für systemischen Lupus erythematodes 9
CTLA4
DNASE1
FCGR2A
FCGR2B
PTPN22
Suszeptibilität für Lupus-Nephritis
FCGR2A
TREX1

Referenzen:

1.

Wu H et al. (2007) Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.

[^]
2.

Yang Y et al. (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.

[^]
3.

Boteva L et al. (2012) Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

[^]
4.

Barreto M et al. (2004) Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.

[^]
5.

Lee YH et al. (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

[^]
6.

Napirei M et al. (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice.

[^]
7.

Yasutomo K et al. (2001) Mutation of DNASE1 in people with systemic lupus erythematosus.

[^]
8.

Shin HD et al. (2004) Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients.

[^]
9.

Balada E et al. (2008) Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus.

[^]
10.

Sanghera DK et al. (1997) Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding.

[^]
11.

Linker-Israeli M et al. (1999) Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression.

[^]
12.

Lee YH et al. (2006) Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility.

[^]
13.

Hom G et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

[^]
14.

Kyogoku C et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

[^]
15.

Orrú V et al. (2009) A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.

[^]
16.

Kyogoku C et al. (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.

[^]
17.

Su K et al. (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus.

[^]
18.

McGaha TL et al. (2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression.

[^]
19.

Blank MC et al. (2005) Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.

[^]
20.

Floto RA et al. (2005) Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts.

[^]
21.

Willcocks LC et al. (2010) A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.

[^]
22.

Mueller M et al. (2013) Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.

[^]
23.

Lee-Kirsch MA et al. (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.

[^]
24.

Yocum MW et al. () Monozygotic twins discordant for systemic lupus erythematosus.

[^]
25.

Beaucher WN et al. (1977) Familial lupus erythematosus. Antibodies to DNA in household dogs.

[^]
26.

Horn JR et al. () Mixed connective tissue disease in siblings.

[^]
27.

Miller KB et al. (1979) Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.

[^]
28.

None (1979) Systemic lupus erythematosus, autoimmunity, sex and inheritance.

[^]
29.

Serdula MK et al. (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii.

[^]
30.

Brustein D et al. (1977) Familial lupus erythematosus.

[^]
31.

Knight JG et al. (1978) Three genes for lupus nephritis in NZB x NZW mice.

[^]
32.

Arnett FC et al. (1976) Studies in familial systemic lupus erythematosus.

[^]
33.

DeHoratius RJ et al. (1975) Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.

[^]
34.

Block SR et al. (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets.

[^]
35.

Sturfelt G et al. (1990) Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population.

[^]
36.

Stohl W et al. (1985) Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.

[^]
37.

Sakane T et al. (1989) Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus.

[^]
38.

Wong DW et al. (1988) Nonlinkage of the T cell receptor alpha, beta, and gamma genes to systemic lupus erythematosus in multiplex families.

[^]
39.

Levcovitz H et al. (1988) Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.

[^]
40.

Green JR et al. (1986) The association of HLA-linked genes with systemic lupus erythematosus.

[^]
41.

Mackie IJ et al. (1987) Familial lupus anticoagulants.

[^]
42.

Baer AN et al. (1986) Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.

[^]
43.

Fronek Z et al. (1986) Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor.

[^]
44.

Halpern R et al. (1985) Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members.

[^]
45.

Theofilopoulos AN et al. (1985) Murine models of systemic lupus erythematosus.

[^]
46.

None (1971) Lupus erythematosus panniculitis (profundus).

[^]
47.

None (1972) Family studies in systemic lupus erythematosus. I. A proband material from central eastern Norway.

[^]
48.

Siegel M et al. (1965) A comparative family study of rheumatoid arthritis and systemic lupus erythematosus.

[^]
49.

Lappat EJ et al. (1968) A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.

[^]
50.

None (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

[^]
51.

Reed WB et al. (1972) Hereditary inflammatory vasculitis with persistent nodules. A genetically-determined new entity probably related to lupus erythematosus.

[^]
52.

Kohler PF et al. (1974) Hereditary angioedema and "familial" lupus erythematosus in identical twin boys.

[^]
53.

None (1973) Familial systemic lupus erythematosus.

[^]
54.

None (1972) Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease.

[^]
55.

Larsen RA et al. (1972) Family studies in systemic lupus erythematosus (SLE). IX. Thyroid diseases and antibodies.

[^]
56.

Siegel M et al. () Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965.

[^]
57.

Batchelor JR et al. (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.

[^]
58.

Solomon G et al. (1983) Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus.

[^]
59.

Steinberg AD et al. (1984) NIH conference. Systemic lupus erythematosus: insights from animal models.

[^]
60.

Hughes GR et al. (1983) Genetics of systemic lupus erythematosus.

[^]
61.

Fielder AH et al. (1983) Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

[^]
62.

Diamond B et al. (1984) Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity.

[^]
63.

Reveille JD et al. (1983) Familial systemic lupus erythematosus: immunogenetic studies in eight families.

[^]
64.

Lahita RG et al. (1983) Familial systemic lupus erythematosus in males.

[^]
65.

Tan EM et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus.

[^]
66.

Reidenberg MM et al. (1980) Acetylator phenotype in idiopathic systemic lupus erythematosus.

[^]
67.

Exner T et al. (1980) Familial association of the lupus anticoagulant.

[^]
68.

Weinberg JB et al. (1980) Analysis of a large pedigree with elliptocytosis, multiple lipomatosis, and biological false-positive serological test for syphilis.

[^]
69.

Morel L et al. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus.

[^]
70.

Sibley JT et al. (1993) Familial systemic lupus erythematosus characterized by digital ischemia.

[^]
71.

None (1996) Systemic lupus erythematosus.

[^]
72.

Vyse TJ et al. (1996) Genetic analysis of autoimmune disease.

[^]
73.

None (1995) Genetics of systemic lupus erythematosus.

[^]
74.

Wu J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

[^]
75.

Vyse TJ et al. (1996) Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice.

[^]
76.

García CO et al. (1996) Autoantibody profile in African-American patients with lupus nephritis.

[^]
77.

Lessard E et al. (1997) Role of CYP2D6 in the N-hydroxylation of procainamide.

[^]
78.

Elçioglu N et al. (1998) Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence?

[^]
79.

Austin-Ward E et al. (1998) Neonatal lupus syndrome: a case with chondrodysplasia punctata and other unusual manifestations.

[^]
80.

None (1998) Chondrodysplasia punctata and maternal systemic lupus erythematosus.

[^]
81.

Gaffney PM et al. (1998) A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families.

[^]
82.

Shai R et al. (1999) Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families.

[^]
83.

Kelly TE et al. (1999) Chondrodysplasia punctata stemming from maternal lupus erythematosus.

[^]
84.

Mohan C et al. (1999) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies.

[^]
85.

Lessard E et al. (1999) Involvement of CYP2D6 activity in the N-oxidation of procainamide in man.

[^]
86.

Lindqvist AK et al. (2000) A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q.

[^]
87.

Gaffney PM et al. (2000) Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families.

[^]
88.

Gross JA et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

[^]
89.

Gray-McGuire C et al. (2000) Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2.

[^]
90.

Zhang J et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.

[^]
91.

Solomou EE et al. (2001) Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus.

[^]
92.

DeGiorgio LA et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.

[^]
93.

Blanco P et al. (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

[^]
94.

Stein CM et al. (2002) Increased prevalence of renal disease in systemic lupus erythematosus families with affected male relatives.

[^]
95.

Leadbetter EA et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

[^]
96.

Graham RR et al. (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus.

[^]
97.

Quintero-Del-Rio AI et al. (2002) The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3).

[^]
98.

Kelly JA et al. (2002) The genetics of systemic lupus erythematosus: putting the pieces together.

[^]
99.

Johanneson B et al. (2002) A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31.

[^]
100.

Scofield RH et al. (2003) Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13.

[^]
101.

Prokunina L et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

[^]
102.

Sun Y et al. (2002) Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease.

[^]
103.

Molokhia M et al. (2003) Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population.

[^]
104.

Baechler EC et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

[^]
105.

Nakamura K et al. (2003) Genetic dissection of anxiety in autoimmune disease.

[^]
106.

None (1964) ANTINUCLEAR ANTIBODIES IN FAMILIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

[^]
107.

Kamat SS et al. (2003) Triplets with systemic lupus erythematosus.

[^]
108.

Russell AI et al. (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.

[^]
109.

Li N et al. (2004) Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus.

[^]
110.

Xu L et al. (2004) Human lupus T cells resist inactivation and escape death by upregulating COX-2.

[^]
111.

Tournoy J et al. (2004) Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice.

[^]
112.

Kozlowski K et al. (2004) Chondrodysplasia punctata in siblings and maternal lupus erythematosus.

[^]
113.

Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

[^]
114.

Tao D et al. (2005) CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus.

[^]
115.

Barber DF et al. (2005) PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.

[^]
116.

Xing C et al. (2005) Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members.

[^]
117.

Lee YH et al. (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis.

[^]
118.

Huerta PT et al. (2006) Immunity and behavior: antibodies alter emotion.

[^]
119.

Aitman TJ et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.

[^]
120.

Graham RR et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

[^]
121.

Kowal C et al. (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

[^]
122.

Fanciulli M et al. (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity.

[^]
123.

Remmers EF et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.

[^]
124.

Kamatani Y et al. (2008) Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population.

[^]
125.

Cunninghame Graham DS et al. (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus.

[^]
126.

et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.

[^]
127.

Kozyrev SV et al. (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.

[^]
128.

Nath SK et al. (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus.

[^]
129.

Oishi T et al. (2008) A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population.

[^]
130.

Willcocks LC et al. (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.

[^]
131.

Graham RR et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus.

[^]
132.

Musone SL et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus.

[^]
133.

Sthoeger ZM et al. (2009) High alpha-defensin levels in patients with systemic lupus erythematosus.

[^]
134.

Sánchez E et al. (2009) Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus.

[^]
135.

Han JW et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.

[^]
136.

Gateva V et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.

[^]
137.

Myouzen K et al. (2010) Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus.

[^]
138.

Niederer HA et al. (2010) Copy number, linkage disequilibrium and disease association in the FCGR locus.

[^]
139.

Guiducci C et al. (2010) TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.

[^]
140.

Olsson LM et al. (2012) Copy number variation of the gene NCF1 is associated with rheumatoid arthritis.

[^]
141.

Manjarrez-Orduño N et al. (2012) CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.

[^]
142.

Kshirsagar S et al. (2014) Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.

[^]
143.

Talaei N et al. (2015) Identification of the SLAM Adapter Molecule EAT-2 as a Lupus-Susceptibility Gene That Acts through Impaired Negative Regulation of Dendritic Cell Signaling.

[^]
144.

Zhao J et al. (2017) A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases.

[^]
145.

Bialas AR et al. (2017) Microglia-dependent synapse loss in type I interferon-mediated lupus.

[^]
Update: 17. Oktober 2019